Insights

Strategic Partnerships Parhelia Biosciences has recent collaboration announcements with Sirona Dx in spatial biology and an exclusive distribution agreement with DKSH for Australia and New Zealand. These partnerships indicate growing channel and ecosystem leverage, suggesting sales opportunities through integrators, distributors, and joint go-to-market activities to expand adoption.

Spatial Biology Focus The company launched Parhelia Spatial Station and emphasizes automated sample preparation for spatial biology workflows (IF, IHC, CODEX, smRNA-FISH, CycIF). This positions Parhelia for opportunities with translational research and clinical trial customers seeking end-to-end automation in spatial assays.

Target Market Fit Customer segments likely include mid-to-large life sciences labs and contract research organizations needing scalable, automated staining and protocol customization. The product suite complements existing instruments from major players, enabling cross-sell of workflow automation and sample prep solutions.

Financial Growth Signals With reported revenue in the range of one to ten million dollars and active fundraising or growth activities indicated by product launches and partnerships, there is potential for channel partnerships, OEM arrangements, and regional distributors to accelerate revenue growth.

Global Expansion Potential Exclusive distribution in ANZ and a multinational partner network suggest opportunities to replicate successful models in other regions. Sales outreach can prioritize regional market entry, localized support, and training services to drive adoption in new geographies.

Similar companies to Parhelia Biosciences

Parhelia Biosciences Tech Stack

Parhelia Biosciences uses 8 technology products and services including Amazon Web Services, Wix, OneTrust, and more. Explore Parhelia Biosciences's tech stack below.

Parhelia Biosciences's Email Address Formats

Parhelia Biosciences uses at least 1 email format:
Parhelia Biosciences Email FormatsExamplePercentage
First@parheliabio.comJohn@parheliabio.com
100%

Frequently Asked Questions

What is Parhelia Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Parhelia Biosciences's official website is parheliabio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Parhelia Biosciences generate?

Minus sign iconPlus sign icon
As of October 2026, Parhelia Biosciences's annual revenue is estimated to be $1M - $10M.

What is Parhelia Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Parhelia Biosciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Parhelia Biosciences have currently?

Minus sign iconPlus sign icon
As of October 2026, Parhelia Biosciences has approximately 12 employees across 2 continents, including North America and Asia. Key team members include Chief Executive Officer: N. S., Chief Operating Officer: R. C. and Chairman: M. S. Explore Parhelia Biosciences's employee directory with LeadIQ.

What industry does Parhelia Biosciences belong to?

Minus sign iconPlus sign icon
Parhelia Biosciences operates in the Biotechnology Research industry.

What technology does Parhelia Biosciences use?

Minus sign iconPlus sign icon
Parhelia Biosciences's tech stack includes Amazon Web Services, Wix, OneTrust, Google Workspace, Sentry, Wistia, Webflow and WP Engine.

What is Parhelia Biosciences's email format?

Minus sign iconPlus sign icon
Parhelia Biosciences's email format typically follows the pattern of First@parheliabio.com. Find more Parhelia Biosciences email formats with LeadIQ.

When was Parhelia Biosciences founded?

Minus sign iconPlus sign icon
Parhelia Biosciences was founded in 2019.
Parhelia Biosciences logo

Parhelia Biosciences

Biotechnology ResearchTexas, United States11-50 Employees

Parhelia Biosciences is a biotechnology research company focused on automating the preparation of microscopic samples. Its system stains cell lines and tissues, including fresh-frozen and FFPE specimens, and supports both coverslips and slide-mounted formats. The platform enables automated workflows across a range of staining and analysis applications, with fully customizable protocols and templates.

Headquartered in Austin, Texas, the company operates as a small to mid-sized player in the biotechnology research sector. A notable recent development is the 2024 launch of the Parhelia Spatial Station, a new sample preparation system for spatial biology.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Parhelia Biosciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.